435 related articles for article (PubMed ID: 28285326)
1. Endogenous opioid system: a promising target for future smoking cessation medications.
Norman H; D'Souza MS
Psychopharmacology (Berl); 2017 May; 234(9-10):1371-1394. PubMed ID: 28285326
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide systems and new treatments for nicotine addiction.
Bruijnzeel AW
Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
[TBL] [Abstract][Full Text] [Related]
3. Endogenous cannabinoid and opioid systems and their role in nicotine addiction.
Maldonado R; Berrendero F
Curr Drug Targets; 2010 Apr; 11(4):440-9. PubMed ID: 20017727
[TBL] [Abstract][Full Text] [Related]
4. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications.
D'Souza MS
Prog Brain Res; 2016; 223():191-214. PubMed ID: 26806777
[TBL] [Abstract][Full Text] [Related]
5. Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.
Berrendero F; Robledo P; Trigo JM; Martín-García E; Maldonado R
Neurosci Biobehav Rev; 2010 Nov; 35(2):220-31. PubMed ID: 20170672
[TBL] [Abstract][Full Text] [Related]
6. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
Nuechterlein EB; Ni L; Domino EF; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
[TBL] [Abstract][Full Text] [Related]
7. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.
Kuwabara H; Heishman SJ; Brasic JR; Contoreggi C; Cascella N; Mackowick KM; Taylor R; Rousset O; Willis W; Huestis MA; Concheiro M; Wand G; Wong DF; Volkow ND
PLoS One; 2014; 9(12):e113694. PubMed ID: 25493427
[TBL] [Abstract][Full Text] [Related]
8. Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
Chiamulera C; Marzo CM; Balfour DJK
Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973
[TBL] [Abstract][Full Text] [Related]
9. Translational Research on Nicotine Dependence.
Falcone M; Lee B; Lerman C; Blendy JA
Curr Top Behav Neurosci; 2016; 28():121-50. PubMed ID: 26873019
[TBL] [Abstract][Full Text] [Related]
10. Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.
Liechti ME; Markou A
CNS Drugs; 2008; 22(9):705-24. PubMed ID: 18698872
[TBL] [Abstract][Full Text] [Related]
11. Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.
Li X; Semenova S; D'Souza MS; Stoker AK; Markou A
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):554-65. PubMed ID: 23752091
[TBL] [Abstract][Full Text] [Related]
12. A critical role for the melanocortin 4 receptor in stress-induced relapse to nicotine seeking in rats.
Qi X; Yamada H; Corrie LW; Ji Y; Bauzo RM; Alexander JC; Bruijnzeel AW
Addict Biol; 2015 Mar; 20(2):324-35. PubMed ID: 24612112
[TBL] [Abstract][Full Text] [Related]
13. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
[TBL] [Abstract][Full Text] [Related]
14. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.
Jackson KJ; Carroll FI; Negus SS; Damaj MI
Psychopharmacology (Berl); 2010 Jun; 210(2):285-94. PubMed ID: 20232057
[TBL] [Abstract][Full Text] [Related]
15. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
Paterson NE; Balfour DJ; Markou A
Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
[TBL] [Abstract][Full Text] [Related]
16. Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status.
Buchhalter AR; Fant RV; Henningfield JE
Drugs; 2008; 68(8):1067-88. PubMed ID: 18484799
[TBL] [Abstract][Full Text] [Related]
17. Activation of Peripheral κ-Opioid Receptors Normalizes Caffeine Effects Modified in Nicotine-Dependent Rats during Nicotine Withdrawal.
Sudakov SK; Bogdanova NG
Bull Exp Biol Med; 2016 Oct; 161(6):743-745. PubMed ID: 27785643
[TBL] [Abstract][Full Text] [Related]
18. Double target concept for smoking cessation.
Wu J
Acta Pharmacol Sin; 2010 Sep; 31(9):1015-8. PubMed ID: 20711220
[TBL] [Abstract][Full Text] [Related]
19. The "stop" and "go" of nicotine dependence: role of GABA and glutamate.
D'Souza MS; Markou A
Cold Spring Harb Perspect Med; 2013 Jun; 3(6):. PubMed ID: 23732855
[TBL] [Abstract][Full Text] [Related]
20. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
